Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Lumbar Degenerative Disc Disease: later-stage trial registry

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Lumbar Degenerative Disc Disease: 2 US clinical trials tracked, none currently recruiting.

Lumbar Degenerative Disc Disease is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Spine BioPharma, running 1 of these trials.

Enrollment posture brief

Registry condition lumbar-degenerative-disc-disease

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Lumbar Degenerative Disc (th…0%
Open-enrollment share among volume-matched conditions near Lumbar Degenerative Disc Disease

Lumbar Degenerative Disc Disease has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Lumbar Degenerative Disc Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Lumbar Degenerative Disc Disease is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Named interventions

Most-linked intervention names on Lumbar Degenerative Disc Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sham Needle Drug
1 trials
SB-01 For Injection Drug
1 trials
BMAC & Allograft Procedure
1 trials
Iliac Crest Bone Graft Procedure
1 trials

US sites by state

Facility locations filed on Lumbar Degenerative Disc Disease trials. A trial with sites in several states counts in each.

New York 2 trials
Ohio 1 trials
Nebraska 1 trials
Kansas 1 trials
Indiana 1 trials
Idaho 1 trials
Georgia 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Lumbar Degenerative Disc Disease page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Lumbar Degenerative Disc Disease trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Spine BioPharma sponsors the most Lumbar Degenerative Disc Disease trials on record, review their full trial history before evaluating a specific study. See Spine BioPharma's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lumbar Degenerative Disc Disease condition card totals 2 registered trials; most-linked intervention Sham Needle; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.